643 related articles for article (PubMed ID: 27334279)
1. Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model.
Ewe A; Höbel S; Heine C; Merz L; Kallendrusch S; Bechmann I; Merz F; Franke H; Aigner A
Drug Deliv Transl Res; 2017 Apr; 7(2):206-216. PubMed ID: 27334279
[TBL] [Abstract][Full Text] [Related]
2. A novel tyrosine-modified low molecular weight polyethylenimine (P10Y) for efficient siRNA delivery in vitro and in vivo.
Ewe A; Przybylski S; Burkhardt J; Janke A; Appelhans D; Aigner A
J Control Release; 2016 May; 230():13-25. PubMed ID: 27061141
[TBL] [Abstract][Full Text] [Related]
3. Tumor tissue slice cultures as a platform for analyzing tissue-penetration and biological activities of nanoparticles.
Merz L; Höbel S; Kallendrusch S; Ewe A; Bechmann I; Franke H; Merz F; Aigner A
Eur J Pharm Biopharm; 2017 Mar; 112():45-50. PubMed ID: 27864052
[TBL] [Abstract][Full Text] [Related]
4. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
[TBL] [Abstract][Full Text] [Related]
5. Liposome-polyethylenimine complexes (DPPC-PEI lipopolyplexes) for therapeutic siRNA delivery in vivo.
Ewe A; Panchal O; Pinnapireddy SR; Bakowsky U; Przybylski S; Temme A; Aigner A
Nanomedicine; 2017 Jan; 13(1):209-218. PubMed ID: 27553077
[TBL] [Abstract][Full Text] [Related]
6. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
[TBL] [Abstract][Full Text] [Related]
7. Storage stability of optimal liposome-polyethylenimine complexes (lipopolyplexes) for DNA or siRNA delivery.
Ewe A; Schaper A; Barnert S; Schubert R; Temme A; Bakowsky U; Aigner A
Acta Biomater; 2014 Jun; 10(6):2663-73. PubMed ID: 24590163
[TBL] [Abstract][Full Text] [Related]
8. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
[TBL] [Abstract][Full Text] [Related]
9. Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol).
Liu L; Zheng M; Librizzi D; Renette T; Merkel OM; Kissel T
Mol Pharm; 2016 Jan; 13(1):134-43. PubMed ID: 26641134
[TBL] [Abstract][Full Text] [Related]
10. Cationic Lipid-Coated Polyplexes (Lipopolyplexes) for DNA and Small RNA Delivery.
Ewe A; Aigner A
Methods Mol Biol; 2016; 1445():187-200. PubMed ID: 27436320
[TBL] [Abstract][Full Text] [Related]
11. Lipidation of polyethylenimine-based polyplex increases serum stability of bioengineered RNAi agents and offers more consistent tumoral gene knockdown in vivo.
Zhang QY; Ho PY; Tu MJ; Jilek JL; Chen QX; Zeng S; Yu AM
Int J Pharm; 2018 Aug; 547(1-2):537-544. PubMed ID: 29894758
[TBL] [Abstract][Full Text] [Related]
12. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
[TBL] [Abstract][Full Text] [Related]
13. Comparative structural and functional studies of nanoparticle formulations for DNA and siRNA delivery.
Kwok A; Hart SL
Nanomedicine; 2011 Apr; 7(2):210-9. PubMed ID: 20709624
[TBL] [Abstract][Full Text] [Related]
14. Biokinetic studies of non-complexed siRNA versus nano-sized PEI F25-LMW/siRNA polyplexes following intratracheal instillation into mice.
Lipka J; Semmler-Behnke M; Wenk A; Burkhardt J; Aigner A; Kreyling W
Int J Pharm; 2016 Mar; 500(1-2):227-35. PubMed ID: 26802492
[TBL] [Abstract][Full Text] [Related]
15. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery.
Höbel S; Prinz R; Malek A; Urban-Klein B; Sitterberg J; Bakowsky U; Czubayko F; Aigner A
Eur J Pharm Biopharm; 2008 Sep; 70(1):29-41. PubMed ID: 18499413
[TBL] [Abstract][Full Text] [Related]
16. Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma.
Höbel S; Appeldoorn CC; Gaillard PJ; Aigner A
Pharmaceuticals (Basel); 2011 Dec; 4(12):1591-1606. PubMed ID: 27721338
[TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo.
Zhupanyn P; Ewe A; Büch T; Malek A; Rademacher P; Müller C; Reinert A; Jaimes Y; Aigner A
J Control Release; 2020 Mar; 319():63-76. PubMed ID: 31866504
[TBL] [Abstract][Full Text] [Related]
18. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.
Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A
J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264
[TBL] [Abstract][Full Text] [Related]
19. Microparticulate poly(vinyl alcohol) hydrogel formulations for embedding and controlled release of polyethylenimine (PEI)-based nanoparticles.
Schulze J; Hendrikx S; Schulz-Siegmund M; Aigner A
Acta Biomater; 2016 Nov; 45():210-222. PubMed ID: 27592816
[TBL] [Abstract][Full Text] [Related]
20. Biscarbamate cross-linked low molecular weight Polyethylenimine polycation as an efficient intra-cellular delivery cargo for cancer therapy.
Ge X; Feng J; Chen S; Zhang C; Ouyang Y; Liu Z; Yuan W
J Nanobiotechnology; 2014 Apr; 12():13. PubMed ID: 24708586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
